- call +1-201-465-4211
- email sales@mrinsights.biz
Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps through colonoscopy in order to prevent it transforming to colon cancer is recommended. Change in bowel habits or blood in stool are the major symptoms of colon cancer. Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation.
Scope of the Report:
This report studies the Colon Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Colon Cancer market by product type and applications/end industries.
According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products. Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.
The global Colon Cancer market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Colon Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bedford Laboratories
Sanofi Aventis
Bayer
GlaxoSmithKline
Teva Pharmaceutical Industries
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Surgery
Chemotherapy
Radiation
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Colon Cancer Market Overview
1.1 Product Overview and Scope of Colon Cancer
1.2 Classification of Colon Cancer by Types
1.2.1 Global Colon Cancer Revenue Comparison by Types (2017-2023)
1.2.2 Global Colon Cancer Revenue Market Share by Types in 2017
1.2.3 Surgery
1.2.4 Chemotherapy
1.2.5 Radiation
1.3 Global Colon Cancer Market by Application
1.3.1 Global Colon Cancer Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Colon Cancer Market by Regions
1.4.1 Global Colon Cancer Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Colon Cancer Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Colon Cancer Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Colon Cancer Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Colon Cancer Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Colon Cancer Status and Prospect (2013-2023)
1.5 Global Market Size of Colon Cancer (2013-2023)
2 Manufacturers Profiles
2.1 Bedford Laboratories
2.1.1 Business Overview
2.1.2 Colon Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bedford Laboratories Colon Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi Aventis
2.2.1 Business Overview
2.2.2 Colon Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Aventis Colon Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Colon Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Colon Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Colon Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Colon Cancer Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva Pharmaceutical Industries
2.5.1 Business Overview
2.5.2 Colon Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Industries Colon Cancer Revenue, Gross Margin and Market Share (2016-2017)
3 Global Colon Cancer Market Competition, by Players
3.1 Global Colon Cancer Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Colon Cancer Players Market Share
3.2.2 Top 10 Colon Cancer Players Market Share
3.3 Market Competition Trend
4 Global Colon Cancer Market Size by Regions
4.1 Global Colon Cancer Revenue and Market Share by Regions
4.2 North America Colon Cancer Revenue and Growth Rate (2013-2018)
4.3 Europe Colon Cancer Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Colon Cancer Revenue and Growth Rate (2013-2018)
4.5 South America Colon Cancer Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Colon Cancer Revenue and Growth Rate (2013-2018)
5 North America Colon Cancer Revenue by Countries
5.1 North America Colon Cancer Revenue by Countries (2013-2018)
5.2 USA Colon Cancer Revenue and Growth Rate (2013-2018)
5.3 Canada Colon Cancer Revenue and Growth Rate (2013-2018)
5.4 Mexico Colon Cancer Revenue and Growth Rate (2013-2018)
6 Europe Colon Cancer Revenue by Countries
6.1 Europe Colon Cancer Revenue by Countries (2013-2018)
6.2 Germany Colon Cancer Revenue and Growth Rate (2013-2018)
6.3 UK Colon Cancer Revenue and Growth Rate (2013-2018)
6.4 France Colon Cancer Revenue and Growth Rate (2013-2018)
6.5 Russia Colon Cancer Revenue and Growth Rate (2013-2018)
6.6 Italy Colon Cancer Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Colon Cancer Revenue by Countries
7.1 Asia-Pacific Colon Cancer Revenue by Countries (2013-2018)
7.2 China Colon Cancer Revenue and Growth Rate (2013-2018)
7.3 Japan Colon Cancer Revenue and Growth Rate (2013-2018)
7.4 Korea Colon Cancer Revenue and Growth Rate (2013-2018)
7.5 India Colon Cancer Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Colon Cancer Revenue and Growth Rate (2013-2018)
8 South America Colon Cancer Revenue by Countries
8.1 South America Colon Cancer Revenue by Countries (2013-2018)
8.2 Brazil Colon Cancer Revenue and Growth Rate (2013-2018)
8.3 Argentina Colon Cancer Revenue and Growth Rate (2013-2018)
8.4 Colombia Colon Cancer Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Colon Cancer by Countries
9.1 Middle East and Africa Colon Cancer Revenue by Countries (2013-2018)
9.2 Saudi Arabia Colon Cancer Revenue and Growth Rate (2013-2018)
9.3 UAE Colon Cancer Revenue and Growth Rate (2013-2018)
9.4 Egypt Colon Cancer Revenue and Growth Rate (2013-2018)
9.5 Nigeria Colon Cancer Revenue and Growth Rate (2013-2018)
9.6 South Africa Colon Cancer Revenue and Growth Rate (2013-2018)
10 Global Colon Cancer Market Segment by Type
10.1 Global Colon Cancer Revenue and Market Share by Type (2013-2018)
10.2 Global Colon Cancer Market Forecast by Type (2018-2023)
10.3 Surgery Revenue Growth Rate (2013-2023)
10.4 Chemotherapy Revenue Growth Rate (2013-2023)
10.5 Radiation Revenue Growth Rate (2013-2023)
11 Global Colon Cancer Market Segment by Application
11.1 Global Colon Cancer Revenue Market Share by Application (2013-2018)
11.2 Colon Cancer Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Colon Cancer Market Size Forecast (2018-2023)
12.1 Global Colon Cancer Market Size Forecast (2018-2023)
12.2 Global Colon Cancer Market Forecast by Regions (2018-2023)
12.3 North America Colon Cancer Revenue Market Forecast (2018-2023)
12.4 Europe Colon Cancer Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Colon Cancer Revenue Market Forecast (2018-2023)
12.6 South America Colon Cancer Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Colon Cancer Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Colon Cancer Picture
Table Product Specifications of Colon Cancer
Table Global Colon Cancer and Revenue (Million USD) Market Split by Product Type
Figur
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
